These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1353449)

  • 1. Synthesis and characterization of biotinylated and photoactivatable neuroleptics. Novel bifunctional probes for dopamine receptors.
    Soskić V; Maelicke A
    Eur J Pharmacol; 1992 Jun; 226(2):109-20. PubMed ID: 1353449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
    Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of novel fluorescent ligands with high affinity for D1 and D2 dopaminergic receptors.
    Monsma FJ; Barton AC; Kang HC; Brassard DL; Haugland RP; Sibley DR
    J Neurochem; 1989 May; 52(5):1641-4. PubMed ID: 2523470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of some phenothiazine derivatives as potential affinity ligands for the central dopamine receptors.
    Soskić V; Maelicke A; Petrovic G; Ristic B; Petrović J
    J Pharm Pharmacol; 1991 Jan; 43(1):27-30. PubMed ID: 1676055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible interaction of beta-haloalkylamine derivatives with dopamine D1 and D2 receptors.
    Cross AJ; Waddington JL; Ross ST
    Life Sci; 1983 Jun; 32(24):2733-40. PubMed ID: 6222234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and dopaminergic features of six novel 3-arylpiperidines.
    Kostic-Rajacic A; Soskic V; Joksimovic J
    Boll Chim Farm; 1998 Nov; 137(10):417-21. PubMed ID: 10025971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of D1 and D2 dopamine receptors in cultured neuroblastoma and retinoblastoma clonal cell lines.
    Monsma FJ; Brassard DL; Sibley DR
    Brain Res; 1989 Jul; 492(1-2):314-24. PubMed ID: 2665904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent and biotin probes for dopamine receptors: D1 and D2 receptor affinity and selectivity.
    Madras BK; Canfield DR; Pfaelzer C; Vittimberga FJ; Difiglia M; Aronin N; Bakthavachalam V; Baindur N; Neumeyer JL
    Mol Pharmacol; 1990 Jun; 37(6):833-9. PubMed ID: 2141665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of N,N-di-n-propyl-5,6,7,8-tetrahydro-1 H-benz[f]benzimidazol-6-yl-amine and related congeners as dopaminergic ligands.
    Dragović D; Soskić V; Joksimović J
    Pharmazie; 1995 Oct; 50(10):678-80. PubMed ID: 7501691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor pharmacology. Its use in neuroleptic research.
    Hyttel J
    Acta Psychiatr Belg; 1987; 87(5):535-51. PubMed ID: 2897759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple fluorescent ligands for dopamine receptors. II. Visualization in neural tissues.
    Ariano MA; Kang HC; Haugland RP; Sibley DR
    Brain Res; 1991 May; 547(2):208-22. PubMed ID: 1884196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New substituted 2-methylthiomethyl- and 2-methylsulphinylmethylenebenzimidazoles with D2/5-HT1A activity.
    Kostić-Rajacić S; Soskić V; Joksimović J
    Pharmazie; 1998 Jul; 53(7):438-41. PubMed ID: 9699220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct visualization and cellular localization of D1 and D2 dopamine receptors in rat forebrain by use of fluorescent ligands.
    Ariano MA; Monsma FJ; Barton AC; Kang HC; Haugland RP; Sibley DR
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8570-4. PubMed ID: 2479025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D2 receptor binding in adrenal medulla: characterization using [3H]spiperone.
    Quik M; Bergeron L; Mount H; Philie J
    Biochem Pharmacol; 1987 Nov; 36(21):3707-13. PubMed ID: 2960326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of N-n-propyl-N-(2-arylethyl)-5-(1H-benzimidazol-2-thione)-eth ylamines and related compounds as potential dopaminergic ligands.
    Soskic V; Dukić S; Dragović D; Joksimović J
    Arzneimittelforschung; 1996 Aug; 46(8):741-6. PubMed ID: 9125270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and properties of several heterocyclic dopaminergic ligands.
    Kostić S; Soskić V; Joksimović J
    Arzneimittelforschung; 1994 Jun; 44(6):697-702. PubMed ID: 7914413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
    Niznik HB; Guan JH; Neumeyer JL; Seeman P
    Mol Pharmacol; 1985 Feb; 27(2):193-9. PubMed ID: 3969068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
    Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V
    Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.